Literature DB >> 17992115

RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line.

Diana E Zamora-Avila1, Moisés A Franco-Molina, Laura M Trejo-Avila, Cristina Rodríguez-Padilla, Diana Reséndez-Pérez, Pablo Zapata-Benavides.   

Abstract

The Wilms' tumor protein 1 (WT1) is essential for tumor cell proliferation and is highly expressed in various hematological and solid malignancies including human malignant melanoma. We investigated whether WT1 expression is essential for growth in the B16F10 murine melanoma cell line. Toward this end, we examined WT1 protein expression and WT1 isoforms (17AA+/17AA-, KTS+/KTS-) in this cell line. WT1 was silenced by two RNA interference constructs, designated WT1-1 and WT1-2. RNA interference-mediated reduction of WT1 protein expression significantly inhibited B16F10 cell viability. Loss of WT1 also increased caspase-3 and poly-ADP-ribose polymerase activation, as well as apoptotic body formation, chromatin condensation, and DNA fragmentation. Together, these findings implicate decreased WT1 protein levels in the induction of apoptosis. These results imply that WT1 plays a distinct role in B16F10 melanoma growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992115     DOI: 10.1097/CMR.0b013e3282efd3ae

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  9 in total

1.  Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells.

Authors:  Saeedeh Ghazaey Zidanloo; Abasalt Hosseinzadeh Colagar; Hossein Ayatollahi; Jahan-Bakhsh Raoof
Journal:  Tumour Biol       Date:  2016-01-27

2.  WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cells.

Authors:  Pablo Zapata-Benavides; Edgar Manilla-Muñoz; Diana E Zamora-Avila; Santiago Saavedra-Alonso; Moisés A Franco-Molina; Laura M Trejo-Avila; Guillermo Davalos-Aranda; Cristina Rodríguez-Padilla
Journal:  Oncol Lett       Date:  2012-01-19       Impact factor: 2.967

3.  WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma.

Authors:  Santiago Saavedra-Alonso; Pablo Zapata-Benavides; Ana Karina Chavez-Escamilla; Edgar Manilla-Muñoz; Diana Elisa Zamora-Avila; Moisés Armides Franco-Molina; Cristina Rodriguez-Padilla
Journal:  Exp Ther Med       Date:  2016-10-27       Impact factor: 2.447

4.  Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.

Authors:  Till Plönes; Mitja Fischer; Kerstin Höhne; Hiromi Sato; Joachim Müller-Quernheim; Gernot Zissel
Journal:  Pathol Oncol Res       Date:  2017-01-04       Impact factor: 3.201

Review 5.  The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.

Authors:  Michael Y Bonner; Jack L Arbiser
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

6.  Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.

Authors:  Rosalba Parenti; Venera Cardile; Adriana Carol Eleonora Graziano; Carmela Parenti; Assunta Venuti; Maria Paola Bertuccio; Debora Lo Furno; Gaetano Magro
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

7.  WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.

Authors:  Mara Artibani; Andrew H Sims; Joan Slight; Stuart Aitken; Anna Thornburn; Morwenna Muir; Valerie G Brunton; Jorge Del-Pozo; Linda R Morrison; Elad Katz; Nicholas D Hastie; Peter Hohenstein
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

8.  Fatty Acids of CLA-Enriched Egg Yolks Can Induce Transcriptional Activation of Peroxisome Proliferator-Activated Receptors in MCF-7 Breast Cancer Cells.

Authors:  Aneta A Koronowicz; Paula Banks; Adam Master; Dominik Domagała; Ewelina Piasna-Słupecka; Mariola Drozdowska; Elżbieta Sikora; Piotr Laidler
Journal:  PPAR Res       Date:  2017-03-26       Impact factor: 4.964

9.  A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems.

Authors:  Mariana H Massaoka; Alisson L Matsuo; Carlos R Figueiredo; Natalia Girola; Camyla F Faria; Ricardo A Azevedo; Luiz R Travassos
Journal:  FEBS Open Bio       Date:  2014-01-21       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.